These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 26364613)

  • 21. Nuclear and extranuclear-initiated estrogen receptor signaling crosstalk and endocrine resistance in breast cancer.
    Kulkoyluoglu E; Madak-Erdogan Z
    Steroids; 2016 Oct; 114():41-47. PubMed ID: 27394959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estradiol induces HOTAIR levels via GPER-mediated miR-148a inhibition in breast cancer.
    Tao S; He H; Chen Q
    J Transl Med; 2015 Apr; 13():131. PubMed ID: 25928008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer.
    Zhang A; Zhao JC; Kim J; Fong KW; Yang YA; Chakravarti D; Mo YY; Yu J
    Cell Rep; 2015 Oct; 13(1):209-221. PubMed ID: 26411689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estradiol-Induced Transcriptional Regulation of Long Non-Coding RNA, HOTAIR.
    Bhan A; Mandal SS
    Methods Mol Biol; 2016; 1366():395-412. PubMed ID: 26585152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of serum exosomal HOTAIR is correlated with poor survival and poor response to chemotherapy in breast cancer patients.
    Tang S; Zheng K; Tang Y; Li Z; Zou T; Liu D
    J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delphinidin-3-glucoside suppresses breast carcinogenesis by inactivating the Akt/HOTAIR signaling pathway.
    Yang X; Luo E; Liu X; Han B; Yu X; Peng X
    BMC Cancer; 2016 Jul; 16():423. PubMed ID: 27388461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibitory effect of calycosin on breast cancer cell progression through downregulating lncRNA HOTAIR and downstream targets: HuR and IGF2BP1.
    Li Y; Miao H; Wei W; Tian J; Chen J
    Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 55(2):225-236. PubMed ID: 36647722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanism of acquired antiestrogen resistance and its management in breast cancer].
    Iino Y; Maemura M; Morishita Y
    Nihon Rinsho; 1997 May; 55(5):1149-54. PubMed ID: 9155167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bisphenol-A and diethylstilbestrol exposure induces the expression of breast cancer associated long noncoding RNA HOTAIR in vitro and in vivo.
    Bhan A; Hussain I; Ansari KI; Bobzean SA; Perrotti LI; Mandal SS
    J Steroid Biochem Mol Biol; 2014 May; 141():160-70. PubMed ID: 24533973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
    Chang SB; Miron P; Miron A; Iglehart JD
    J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.
    Milevskiy MJ; Al-Ejeh F; Saunus JM; Northwood KS; Bailey PJ; Betts JA; McCart Reed AE; Nephew KP; Stone A; Gee JM; Dowhan DH; Dray E; Shewan AM; French JD; Edwards SL; Clark SJ; Lakhani SR; Brown MA
    Hum Mol Genet; 2016 Aug; 25(15):3269-3283. PubMed ID: 27378691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. JMJD6 induces HOTAIR, an oncogenic lincRNA, by physically interacting with its proximal promoter.
    Biswas A; Shettar A; Mukherjee G; Kondaiah P; Desai KV
    Biochem J; 2018 Jan; 475(1):355-371. PubMed ID: 29229759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long Noncoding RNA HOTAIR Modulates MiR-206-mediated Bcl-w Signaling to Facilitate Cell Proliferation in Breast Cancer.
    Ding W; Ren J; Ren H; Wang D
    Sci Rep; 2017 Dec; 7(1):17261. PubMed ID: 29222472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Long Noncoding RNA HOTAIR in Breast Cancer: Does Autophagy Play a Role?
    Pawłowska E; Szczepanska J; Blasiak J
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29469819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells.
    Vendrell JA; Ghayad S; Ben-Larbi S; Dumontet C; Mechti N; Cohen PA
    Oncogene; 2007 Jul; 26(32):4656-67. PubMed ID: 17297453
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.
    Gökmen-Polar Y; Toroni RA; Hocevar BA; Badve S; Zhao Q; Shen C; Bruckheimer E; Kinch MS; Miller KD
    Breast Cancer Res Treat; 2011 Jun; 127(2):375-84. PubMed ID: 20602165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.